Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 28, 2021

SELL
$56.61 - $80.46 $1.54 Million - $2.19 Million
-27,260 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$86.23 - $125.19 $105,631 - $153,357
1,225 Added 4.71%
27,260 $2.53 Million
Q4 2020

Jan 27, 2021

BUY
$79.17 - $111.47 $2,137 - $3,009
27 Added 0.1%
26,035 $2.33 Million
Q3 2020

Oct 22, 2020

SELL
$81.91 - $134.94 $22,033 - $36,298
-269 Reduced 1.02%
26,008 $2.69 Million
Q2 2020

Jul 20, 2020

BUY
$54.33 - $89.52 $7,280 - $11,995
134 Added 0.51%
26,277 $2.08 Million
Q1 2020

May 01, 2020

SELL
$49.34 - $68.76 $23,535 - $32,798
-477 Reduced 1.79%
26,143 $1.51 Million
Q4 2019

Jan 31, 2020

BUY
$51.21 - $59.06 $2,458 - $2,834
48 Added 0.18%
26,620 $1.44 Million
Q3 2019

Nov 08, 2019

SELL
$40.6 - $57.2 $5,278 - $7,436
-130 Reduced 0.49%
26,572 $1.39 Million
Q2 2019

Jul 24, 2019

SELL
$39.92 - $53.86 $4,391 - $5,924
-110 Reduced 0.41%
26,702 $1.29 Million
Q1 2019

May 09, 2019

BUY
$48.23 - $66.16 $279,203 - $383,000
5,789 Added 27.54%
26,812 $1.36 Million
Q4 2018

Feb 06, 2019

BUY
$55.63 - $73.24 $117,824 - $155,122
2,118 Added 11.2%
21,023 $1.25 Million
Q2 2018

Jul 30, 2018

BUY
$48.33 - $55.64 $20,540 - $23,647
425 Added 2.3%
18,905 $955,000
Q1 2018

May 09, 2018

SELL
$44.44 - $54.39 $26,664 - $32,634
-600 Reduced 3.14%
18,480 $973,000
Q4 2017

Feb 01, 2018

BUY
$37.77 - $47.75 $6,798 - $8,595
180 Added 0.95%
19,080 $887,000
Q2 2017

Aug 09, 2017

BUY
N/A
18,900
18,900 $641,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $395M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Chatham Capital Group, Inc. Portfolio

Follow Chatham Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.